a multicentric validation of a rapid detection test for ... · revised abstract background the...

1
R EVISED ABSTRACT Background The emergence and spread of Enterobacteriaceae resistant to critically important antibiotics such as carbapenems is a matter of great public Health concern. Accordingly, colistin, a cationic polypeptide introduced in the 1950s, has become a last-resort molecule that has been increasingly prescribed in clinics in the last years. Of note, colistin is also widely used in the food animal sector. Late 2015, a plasmid-born colistin resistant gene (mcr-1) was reported, and a rapid detection of MCR-1-producing bacteria is essential to prevent further spread and provide appropriate antimicrobial therapy. Here, we provide validation data of a Lateral Flow ImmunoAssay (LFIA) to detect MCR-1 producers within 15 minutes. Methods LFIA (strip + cassette) were manufactured using monoclonal antibodies previously produced and selected. A retrospective collection of mcr-1-positive enterobacterial isolates of human and animal origin was tested in a multicentric way. The isolates were grown on agar and one colony was suspended in extraction buffer and then dispensed on the cassette. Migration was allowed for 15 minutes and results were monitored by the appearance of a specific band. Results Positive results showed a dark pink colored band leading to no ambiguous interpretation. All mcr-1-positive isolates were detected as positive by the LFIA test and no false negative result was observed. Three out of four strains producing MCR-2 were detected positives. Our test does not detect MCR-3-; MCR-4 or MCR-5- producing bacteria. Conclusions Our LFIA is able to detect MCR-1 with 100% sensitivity and 98% specificity. It also appears usable for the detection of MCR-2 (3/4) but further studies are needed to better assess the performances of MCR-2 detection. It is compatible with samples handled in laboratories. This test is rapid, sensitive, specific, easy to use, cost-effective and could thus be implemented in any microbiology laboratory around the world. Considering the relevance of colistin resistance in humans and animals, and the possible transfers of MCR producers between them, the LFIA test could be of major help for diagnostic and monitoring purposes in the two sectors. A multicentric validation of a rapid detection test for MCR - 1 producing bacteria Hervé Volland 1 , Anaïs Vogel 1 , Sandrine Bernabeu 2 , Hervé Boutal 1 , Marisa Haenni 3 , Jean-Yves Madec 3 , Frédéric Robin 4 , Racha Beyrouthy 4 , Karine Devilliers 1 , Laurent Dortet 2 , Marc Plaisance 1 , Thierry Naas 2 , Stéphanie Simon 1 1 Service de Pharmacologie et Immuno-analyse (SPI), JOLIOT, CEA, INRA, Université Paris-Saclay, F-91191, Gif sur Yvette, FRANCE 2 EA7361, UPSUD, Hôpital de Bicêtre, APHP. Le Kremlin Bicêtre France 3 Unité Antibiorésistance et virulence bactériennes (AVB), Anses Lyon, Université Lyon, 69364 Lyon 07, France 4 CHU Clermont-Ferrand, Laboratoire de Bactériologie & CNR de la Résistance aux Antibiotiques, Clermont-Ferrand, France Contact: [email protected] Phone: +33 1 69 08 79 98 MCR-1 lateral flow immunoassay (LFIA) development NG-Test MCR-1 validation: manufactured tests from NG Biotech Antibodies recognizing labelled antibodies (control line) Absorption pad Sample Antibody pairs recognizing mcr-1. One antibody of the pair labelled with colloidal gold, the other immobilized on nitrocellulose (test line) Sample pad Nitrocellulose S trip Sample flow : capillarity M ONOCLONAL ANTIBODIES ( m A BS ) , PRODUCTION AND SELECTION Mice were immunized with purified recombinant perisplasmic region of MCR-1 (p-MCR-1) 20 mAbs were selected and purified Combinatorial testing: 400 pairs, 800 strips (0 and 50 ng/ml of p-MCR-1) I MMUNOCHROMATOGRAPHIC ASSAY PRINCIPLE R ESULTS All the MCR-1 producing strains gave a positive result, except 1 MCR-1-producing but colistin susceptible isolate 3/4 of the MCR-2 producing isolates gave a positive test result All the other strips gave a negative result Conclusions and perspectives Our LFIA is able to detect MCR-1 with 100% sensitivity and 98% specificity Our test might be implemented in any human or animal or microbiology diagnostic laboratory Our LFIA is easy to used, rapid, sensitive The NG-Test MCR-1 is commercially-available The NG-Test MCR-1 could be a very useful tool for the monitoring of the MCR-1 dissemination + Detection Results MCR-1 lateral flow immunoassay evaluation Selection of one pair used for MCR-1 LFIA evaluation Limit of detection (migration time 15 minutes) 0 5 3 1 0,3 ng/ml of p-MCR-1 0 6 10 8 2 10 8 cfu/ml of MCR-1 producing E. coli (Due to the camera sensitivity positive test lines at 300 pg/ml and 2.10 8 CFU/ml don’t appear on the picture but these lines are clearly visible) Cross - reactivity (migration time 15 minutes) 1 2 3 4 5 6 7 8 9 10 11 12 1-E. coli MCR-1 2-C. freundii CTXM-1 3-E. coli CTXM-2 4-K. oxytoca CTXM-14 9-C. koseri OXA-48 2B9 10-K. pneumoniae OXA-162 11-E. cloacae OXA-163 12-E. coli OXA-244 5-K. pneumoniae CTXM-18 6-K. pneumoniae CTXM-19 7-P. aeruginosa IMP-2 8-S. marcescens IMP-11 A positive test is obtained only with the strain producing MCR-1 all other tests are negative whatever the strain or beta-lactamase produced Detection limits are 0,3 ng/ml of purified p-MCR-1 and 2 10 8 cfu/ml of MCR-1 producing E. coli P ROTOCOLE One colony from agar plate was suspended in 150μl of extraction buffer (extraction step). After vortexing 100μl were loaded on the cassette. Migration 15’ before naked eye reading. The tests were realized at the 3 locations R ETROSPECTIVE VALIDATION - 298 strains from 3 different locations: Hôpital Bicêtre (Paris, France); Anses (Lyon, France) and CHU Clermont-Ferrand (Clermont Ferrand, France) - Origin: Isolates from human (177) or animal (121) samples - Isolates: 221 Escherichia coli; 48 Klebsiella pneumoniae; 16 Enterobacter cloacae; 8 Salmonella sp; 2 Hafnia alvei; 1 Shewanella oneidensis;1 Shewanella profunda; 1 Citrobacter freundii - 109 MCR-1 producing strains and colistin resistant - 1 MCR-1 producing strains and colistin susceptible (MIC<0,5 μg/ml) - 4 MCR-2 producing strains and colistin resistant - 16 MCR-3 producing strains and colistin resistant - 2 MCR-3 producing strains and colistin susceptible (MIC<0,5 μg/ml) - 5 MCR-4 producing strains and colistin resistant - 3 MCR-5 producing strains and colistin resistant - 91 non MCR producing strains and colistin resistant - 67 non MCR producing strains and colistin susceptible (MIC<0,5 μg/ml) no MCR producing strains colistin resistant MCR-1 producing strains colistin resistant MCR producing strains colistin susceptible MCR-3 producing strains colistin resistant S OME TEST EXAMPLES

Upload: others

Post on 09-Oct-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: A multicentric validation of a rapid detection test for ... · REVISED ABSTRACT Background The emergence and spread of Enterobacteriaceae resistant to critically important antibiotics

REVISED ABSTRACT

BackgroundThe emergence and spread of Enterobacteriaceae resistant tocritically important antibiotics such as carbapenems is a matterof great public Health concern. Accordingly, colistin, a cationicpolypeptide introduced in the 1950s, has become a last-resortmolecule that has been increasingly prescribed in clinics in thelast years. Of note, colistin is also widely used in the food animalsector. Late 2015, a plasmid-born colistin resistant gene (mcr-1)was reported, and a rapid detection of MCR-1-producingbacteria is essential to prevent further spread and provideappropriate antimicrobial therapy. Here, we provide validationdata of a Lateral Flow ImmunoAssay (LFIA) to detect MCR-1producers within 15 minutes.MethodsLFIA (strip + cassette) were manufactured using monoclonalantibodies previously produced and selected. A retrospectivecollection of mcr-1-positive enterobacterial isolates of humanand animal origin was tested in a multicentric way. The isolateswere grown on agar and one colony was suspended inextraction buffer and then dispensed on the cassette. Migrationwas allowed for 15 minutes and results were monitored by theappearance of a specific band.ResultsPositive results showed a dark pink colored band leading to noambiguous interpretation. All mcr-1-positive isolates weredetected as positive by the LFIA test and no false negative resultwas observed. Three out of four strains producing MCR-2 weredetected positives. Our test does not detect MCR-3-; MCR-4 orMCR-5- producing bacteria.ConclusionsOur LFIA is able to detect MCR-1 with 100% sensitivity and 98%specificity. It also appears usable for the detection of MCR-2(3/4) but further studies are needed to better assess theperformances of MCR-2 detection. It is compatible with sampleshandled in laboratories. This test is rapid, sensitive, specific, easyto use, cost-effective and could thus be implemented in anymicrobiology laboratory around the world. Considering therelevance of colistin resistance in humans and animals, and thepossible transfers of MCR producers between them, the LFIAtest could be of major help for diagnostic and monitoringpurposes in the two sectors.

A multicentric validation of a rapid detection test for MCR-1 producing bacteriaHervé Volland1, Anaïs Vogel1, Sandrine Bernabeu2, Hervé Boutal1, Marisa Haenni3, Jean-Yves Madec3, Frédéric Robin4, Racha Beyrouthy4, Karine Devilliers1, Laurent Dortet2, Marc Plaisance1, Thierry Naas2, Stéphanie Simon1

1 Service de Pharmacologie et Immuno-analyse (SPI), JOLIOT, CEA, INRA, Université Paris-Saclay, F-91191, Gif sur Yvette, FRANCE2 EA7361, UPSUD, Hôpital de Bicêtre, APHP. Le Kremlin Bicêtre France3 Unité Antibiorésistance et virulence bactériennes (AVB), Anses Lyon, Université Lyon, 69364 Lyon 07, France4 CHU Clermont-Ferrand, Laboratoire de Bactériologie & CNR de la Résistance aux Antibiotiques, Clermont-Ferrand, France

Contact: [email protected]: +33 1 69 08 79 98

MCR-1 lateral flow immunoassay (LFIA) development NG-Test MCR-1 validation: manufactured tests from NG Biotech

Antibodiesrecognizing labelledantibodies (control line)

Absorption pad

Sample

Antibody pairs recognizingmcr-1. One antibody of thepair labelled with colloidalgold, the other immobilized onnitrocellulose (test line)

Sample pad Nitrocellulose

Strip

Sample flow : capillarity

MONOCLONAL ANTIBODIES (mABS) , PRODUCTION AND SELECTION

Mice were immunized with purified recombinant perisplasmic region of MCR-1 (p-MCR-1)20 mAbs were selected and purifiedCombinatorial testing: 400 pairs, 800 strips (0 and 50 ng/ml of p-MCR-1)

IMMUNOCHROMATOGRAPHIC ASSAY PRINCIPLE

RESULTS

All the MCR-1 producing strains gave a positive result, except 1 MCR-1-producing but colistin susceptible isolate3/4 of the MCR-2 producing isolates gave a positive test resultAll the other strips gave a negative result

Conclusions and perspectives

Our LFIA is able to detect MCR-1 with 100% sensitivity and 98% specificity

Our test might be implemented in any human or animal or microbiology diagnostic laboratory

Our LFIA is easy to used, rapid, sensitive

The NG-Test MCR-1 is commercially-available

The NG-Test MCR-1 could be a very useful tool for the monitoring of the MCR-1 dissemination

+

Detection Results

MCR-1 lateral flow immunoassay evaluation

Selection of one pair used for MCR-1 LFIA evaluation

Limit of detection (migration time 15 minutes)

0 5 3 1 0,3

ng/ml of p-MCR-1

0 6 108 2 108

cfu/ml of MCR-1 producing E. coli

(Due to the camera sensitivity positive test lines at 300 pg/ml and 2.108 CFU/ml don’t appear on the picture but these lines are clearly visible)

Cross-reactivity (migration time 15 minutes)

1 2 3 4 5 6 7 8 9 10 11 12

1-E. coli MCR-12-C. freundii CTXM-13-E. coli CTXM-24-K. oxytoca CTXM-14

9-C. koseri OXA-48 2B9 10-K. pneumoniae OXA-16211-E. cloacae OXA-163 12-E. coli OXA-244

5-K. pneumoniae CTXM-186-K. pneumoniae CTXM-197-P. aeruginosa IMP-28-S. marcescens IMP-11

A positive test is obtained only with the strain producing MCR-1 all other tests are negativewhatever the strain or beta-lactamase produced

Detection limits are 0,3 ng/ml of purified p-MCR-1 and 2 108 cfu/ml of MCR-1 producing E. coli

PROTOCOLE

One colony from agar plate was suspended in 150µl of extraction buffer (extraction step). After vortexing 100µl were loaded on the cassette. Migration 15’ before naked eye reading.The tests were realized at the 3 locations

RETROSPECTIVE VALIDATION

- 298 strains from 3 different locations: Hôpital Bicêtre (Paris, France); Anses (Lyon, France) and CHU Clermont-Ferrand (Clermont Ferrand, France)- Origin: Isolates from human (177) or animal (121) samples- Isolates: 221 Escherichia coli; 48 Klebsiella pneumoniae; 16 Enterobacter cloacae; 8 Salmonella sp; 2 Hafnia alvei; 1 Shewanellaoneidensis; 1 Shewanella profunda; 1 Citrobacter freundii

- 109 MCR-1 producing strains and colistin resistant - 1 MCR-1 producing strains and colistin susceptible (MIC<0,5 µg/ml)- 4 MCR-2 producing strains and colistin resistant - 16 MCR-3 producing strains and colistin resistant - 2 MCR-3 producing strains and colistin susceptible (MIC<0,5 µg/ml)- 5 MCR-4 producing strains and colistin resistant - 3 MCR-5 producing strains and colistin resistant - 91 non MCR producing strains and colistin resistant - 67 non MCR producing strains and colistin susceptible (MIC<0,5 µg/ml)

no MCR producing strains colistin resistant

MCR-1 producing strainscolistin resistant

MCR producing strainscolistin susceptible

MCR-3 producing strainscolistin resistant

SOME TEST EXAMPLES